UNSPSC 42311606: Topical hemostatic agents

In this classification, this commodity indicates a product used as a mixture used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure in a medical setting Most nations, for tariff and trade purposes, schedule these products under HS 300339.

UNSPSC 42311606 Topical hemostatic agents (Commodity) covers specialized bleeding-control products used in emergency medical and tactical contexts, though recent state and local solicitation activity under this code shows minimal direct relevance to the narrow commodity scope. The single recent opportunity tagged to this code is Sourcewell RFP #061626, a cooperative purchasing vehicle issued by Sourcewell (a Minnesota local government unit) on behalf of participating counties including Franklin, Grant, Grays Harbor, Chelan, and Yakima in Washington state, seeking to establish a law enforcement equipment contracting solution with proposals due June 16, 2026. The solicitation is structured to serve thousands of governmental agencies, K–12 school districts, higher education institutions, tribal governments, and other public entities across the United States and Canada through a participating addendum framework. The RFP does not identify set-aside designations, specific budget ranges, or incumbent vendors in available documentation.

The code shows activity concentrated in Washington state and Minnesota through the Sourcewell cooperative mechanism, though the law enforcement equipment procurement encompasses a national scope. Vendors submitting to Sourcewell RFP #061626 must create an account on the Sourcewell Procurement Portal (https://proportal.sourcewell-mn.gov) and submit all responses and questions through that platform by the June 16, 2026 deadline at 3:30 p.m. Central Time. Contact is Mari Vielma at rfp@sourcewell-mn.gov or 888-894-1930 for general procurement questions. The mismatch between the hemostatic-agent commodity definition and the law enforcement equipment solicitation tagging suggests this code sees minimal targeted activity aligned with its intended scope; firms evaluating the code should verify whether recent state and local buyers are actually soliciting topical hemostatic agents under separate opportunities not yet captured in the available data.